Shopping Cart
- Remove All
Your shopping cart is currently empty
CZC-25146 (CHEMBL2397014) is an effective, specific and metabolically stable LRRK2 inhibitor with IC50 of 4.76/6.87 nM for wild-type LRRK2(Leucine-rich repeat kinase-2) and G2019S LRRK2, respectively.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 10 mg | $48 | In Stock | |
| 25 mg | $106 | In Stock | |
| 50 mg | $193 | In Stock | |
| 100 mg | $276 | In Stock | |
| 200 mg | $401 | In Stock | |
| 1 mL x 10 mM (in DMSO) | $31 | In Stock |
| Description | CZC-25146 (CHEMBL2397014) is an effective, specific and metabolically stable LRRK2 inhibitor with IC50 of 4.76/6.87 nM for wild-type LRRK2(Leucine-rich repeat kinase-2) and G2019S LRRK2, respectively. |
| Targets&IC50 | LRRK2:4.76 nM, LRRK2 (G2019S):6.87 nM |
| Synonyms | CHEMBL2397014 |
| Molecular Weight | 488.54 |
| Formula | C22H25FN6O4S |
| Cas No. | 1191911-26-8 |
| Smiles | COc1cc(ccc1Nc1ncc(F)c(Nc2ccccc2NS(C)(=O)=O)n1)N1CCOCC1 |
| Relative Density. | 1.436 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 60 mg/mL (122.81 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.